Astrazeneca Pharma India Achieves 52-Week High Amid Broader Market Decline
Astrazeneca Pharma India has achieved a new 52-week high of Rs. 9413.6, outperforming its sector significantly. The stock has gained 18.62% over three days and opened with a 6.01% increase today. Its strong performance contrasts with broader market challenges, highlighting its robust position in the pharmaceuticals sector.
Astrazeneca Pharma India has made headlines today as its stock price reached a new 52-week high of Rs. 9413.6, marking a significant milestone for the company. This achievement comes amidst a strong performance, with the stock outperforming its sector by 16.88%. Over the past three days, Astrazeneca Pharma India has shown impressive momentum, gaining 18.62% in returns.Today, the stock opened with a notable gain of 6.01% and touched an intraday high of Rs. 9413.6, reflecting an increase of 18.1%. The stock has exhibited high volatility, with an intraday volatility rate of 6.34%. Furthermore, Astrazeneca Pharma India is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend.
In contrast, the broader market has faced challenges, with the Sensex opening lower and experiencing a three-week consecutive decline. Despite this, Astrazeneca Pharma India's one-year performance stands out, boasting a remarkable 51.41% increase compared to the Sensex's 10.08%. This performance underscores the company's robust position within the pharmaceuticals and biotechnology industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
